Moderna Some Approvals Ahead: Is the Stock a Buy?
Moderna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
Index benchmarks provide a transparent yardstick for performance, helping investors gauge risk-adjusted returns and make informed choices.
27,627 articlesModerna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
Netflix stock surged last Friday on news that the company walked away from a mega-deal. This guide explains what happ...
This week brought a sharp decline in lenz therapeutics stock plummeted as concerns about revenue growth and financing...
AMD reported robust Q1 2026 results, with data center revenue surging and strategic AI partnerships signaling a durab...
When Intuitive Machines announced a major equity raise, the stock sold off hard. But a disciplined look shows the mov...
Kaspi.kz faces a pivotal year as it expands its super app, grows its loan book, and navigates regional headwinds. Thi...
Toncoin surged 36% after Telegram pledged near-zero fees, sparking a broader rally in TON-related tokens. This articl...
As ATS gears up for its Q4 2026 results, investors want clarity on revenue momentum, margins, and guidance. This arti...
Britain’s central bank shifts how stablecoins are regulated, removing strict per-coin caps and allowing larger reserv...
As March moves unfold, the stock market today is colored by big auto headlines. Ford’s recall news sent ripples throu...
IonQ is moving from early-stage hardware to recurring cloud access and software tools. This article breaks down what ...
ibit’s hidden advantage: in-kind redemptions could reshape tracking and costs for the largest US spot Bitcoin ETF as ...